Skip to main content
Clinical Trials/CTRI/2025/02/080919
CTRI/2025/02/080919Not yet recruitingNot Applicable

Utility of Repertory of Herings Guiding Symptoms of Our Materia Medica By Calvin B.Knerr In The Treatment OF Rhinosinusitis.

Dr Khadijah Arshad1 site in 1 country30 target enrollmentStarted: February 24, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
To compare the Rhinosinusitis SNOT-22 at baseline and after 6 months of treatment to know the utility of individualized homoeopathic medicine.

Study Overview

Brief Summary

This is an open label, single arm, prospective, interventional study which aims to assess the utility of homoeopathic medicine in the treatment of Rhinosinusitis with the help of Hering’s guiding symptoms of our materia medica by Calvin B. Knerr repertory. Individualized homoeopathic medicine will be prescribed in decimal/ centesimal scale after detailed case taking and repertorization. Rhinosinusitis is a group of disorders characterized by inflammation of the mucosa of the nose and paranasal sinuses. Prevalence rate of chronic rhinosinusitis range from 1% to 12% worldwide. . 1 in 8 Indians is hit by chronic sinusitis. Among respiratory infections, rhinosinusitis is one of the most common illnesses that affects a high proportion of the population. Conventional medicines treats rhinosinusitis with the help of antibiotics, steroids, antihistamines for its relief. The overuse of nasal decongestants can also lead to a condition called rebound congestion in which the person has prolonged stuffiness and nose blockage. Homoeopathic remedies can offer gentle and safe treatment for patients suffering from Rhinosinusitis.  Homoeopathy treats the person as a whole. This includes a detailed medical history of the patient, family and causative factors. Any underlying predisposing factor and susceptibility is also considered.

Therefore, the present study is undertaken to explore how individualized homoeopathic medicine selected on the basis of Repertory Of HERING GUIDING’S SYMPTOMS OF OUR MATERIA MEDICA BY CALVIN B. KNERR  useful in the treatment of Rhinosinusitis .Individualized homoeopathic medicine has  shown  very good results .However ,research studies to further elaborate as well as consolidate  our knowledge is still lacking. There  has been a limited research on Repertory Of HERING’S GUIDING SYMPTOMS OF OUR MATERIA MEDICA BY CALVIN B.KNERR in the treatment of rhinosinusitis. Therefore, intend to undertake this study to research in this particular domain.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
1.00 Day(s) to 99.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patient of all age group.
  • Both the sexes will be considered 3)Diagnostic criteria are mainly on clinical presentation and X-ray PNS will be done when required.
  • Those who agree to give consent to participate in the study.
  • Those who are willing to have regular follow up visits.

Exclusion Criteria

  • Patients with complications of other autoimmune diseases.
  • Patients with Immunocompromised disease 3)Mentally retarded patients 4)Patients with congenital defect.
  • Rhinosinusitis presenting with complications like orbital abscess, mucopyocele, oedema of eyelids, meningitis.
  • Patients with chronic respiratory condition like severe asthma.
  • Paranasal sinus and nose surgery.
  • Pregnant and lactating women.

Outcomes

Primary Outcomes

To compare the Rhinosinusitis SNOT-22 at baseline and after 6 months of treatment to know the utility of individualized homoeopathic medicine.

Time Frame: 12weeks, 24 weeks.

Secondary Outcomes

  • To compare the X-ray results at baseline and after 3(months of treatment to know the utility of individualized)

Investigators

Sponsor
Dr Khadijah Arshad
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Khadijah arshad

State national homoeopathic medical college and hospital

Study Sites (1)

Loading locations...

Similar Trials